Homebiotech

biotech

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026

biotech

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

Jim Cornall - June 25, 2026

biotech

Meteor Biotech joins brain organoids consortium

Jim Cornall - June 25, 2026

biotech

Can food influence gene activity?

Jim Cornall - June 24, 2026

biotech

Perceptive Discovery and Pfizer launch FIBRE consortium for fibrosis drug development

Jim Cornall - June 26, 2025

biotech

Unlocking rapid CAR-T cell expansion

Jim Cornall - June 26, 2025

biotech

Smart mRNA drugs that listen to the body

Jim Cornall - June 26, 2025

biotech

New insights into genome ejection from AAV vectors

Jim Cornall - June 25, 2025

biotech

New drug for diabetes and obesity shows promising results

Jim Cornall - June 25, 2025

biotech

Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Jim Cornall - June 25, 2025

biotech

New nanoparticles offer safer, more effective drug delivery

Jim Cornall - June 25, 2025

biotech

Two key proteins perform powerful functions on a major secretory pathway

Jim Cornall - June 24, 2025

1...787980...85 Page 79 of 85

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Vedana Therapeutics launches to develop migraine therapies

Jim Cornall - June 25, 2026 0

Vedana Therapeutics, a biotechnology company developing next-generation therapies for migraine prevention, has emerged from stealth with $46m in Series A financing. The financing was co-led...

Memento Medicines launches with $93m to develop antibody therapy for retinal diseases

biotech Jim Cornall - June 25, 2026 0

Meteor Biotech joins brain organoids consortium

biotech Jim Cornall - June 25, 2026 0

Can food influence gene activity?

biotech Jim Cornall - June 24, 2026 0

Lab-engineered proteins: a promising treatment for liver disease

biotech Jim Cornall - June 24, 2026 0